Wyeth (JOBS) Narrows Focus of Early-Stage Research

NEW YORK, Oct 28 (Reuters) - Wyeth said on Tuesday it would narrow its early-stage research to a half-dozen therapeutic areas, but would continue to sell existing products and conduct research on drugs already in development.
MORE ON THIS TOPIC